obesity drug news today glp-1 october 21 2025 Outlook for in 2025: more than a transition year The popularity of GLP-1 drugs
Description
Clin Ther 2020
In humans, LPS infusion raises GLP-1 levels in healthy young subjects (9)
Ozempic (semaglutide) has dominated the GLP-1 market due to its early approval, strong efficacy in glycemic control, and weekly administration convenience
Since the cost of these drugs can be prohibitive, these findings could have a major real-world impact, says Mitch Biermann, MD, PhD, an author of the study and an obesity medicine and internal medicine doctor at Scripps Clinic Carmel Valley in California
Robert et al., 2015)
